Interestingly, EZH2 was found to methylate cytoplasmic proteins involved in Akt-signaling [46], suggesting that the oncogenic role of EZH2 in breast cancer could also be unrelated to its role in epigenetic regulation. The gene discussed is AKT1; the disease is breast carcinoma.